Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Promoting affordable access to new medicines: a State of Health in the EU webinar
8+ hour, 6+ min ago (115+ words) Access to medicines is under pressure across the EU, as rising prices for new therapies and growing demand test the limits of public budgets. Between 2020 and 2025, Member States implemented wide-ranging reforms to expand coverage, reduce out-of-pocket costs, and sustain innovation....
Regal Partners Increases Stake in OncoSil Medical to 13.82% Following Multiple Transactions
9+ hour, 24+ min ago (69+ words) Kalkine Media OncoSil Medical (ASX:OSL) OSL (ASX:OSL) announced a change in substantial holder interests from Regal Partners Funds Management Pty Limited and its associates, revealing their voting power rose from 9.25% to 13.82%. This is based on the total shares…...
US push to cut drug prices could mean longer waits for European patients
11+ hour, 48+ min ago (942+ words) Last May, US President Donald Trump pushed to align drug pricing with the lowest levels among other developed nations — so-called most-favoured-nation (MFN) pricing. However, the pricing policy might have negative consequences. European patients might have to wait longer for some…...
Otsuka Arm's Lung Cancer Drug Plus Chemotherapy Trial Shows Six-Month Median PFS Benefit
11+ hour, 43+ min ago (41+ words) marketscreener.com Otsuka Holdings Co., Ltd. Otsuka Arm's Lung Cancer Drug Plus Chemotherapy Trial Shows Six-Month Median PFS Benefit Published on 09/14/2026 at 01:08 am EDT...
The System Is Not the Patient
12+ hour, 37+ min ago (316+ words) Across OECD countries, healthcare spending has long grown faster than GDP, while health-adjusted life expectancy has stagnated or declined and up to 20% of spending remains directed to low-value care. Outcome-based care measures success by patient outcomes relative to resources used,…...
Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends
13+ hour, 37+ min ago (131+ words) PharmaDispatch Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends Six patients who had lived with binge eating disorder for as long as two decades sat down for two infusions of an experimental psychedelic drug....
Committee concerned cancer cuts will cost lives
13+ hour, 51+ min ago (737+ words) Federal Government plans to stop funding its Prostate Cancer Specialist Nursing Program could cost lives, particularly in rural and regional areas, says Shepparton’s Biggest Ever Blokes Lunch Committee. The government announced on August 31 its intention to end funding for the…...
Entropy Neurodynamics Confirms Durable Clinical Response in TRP-8803 BED Trial
9+ hour, 48+ min ago (367+ words) Entropy Neurodynamics reports durable 12-week BED response from TRP-8803, with 50% binge-free and 73% weekly episodes below baseline after two doses. Entropy Neurodynamics (ASX: ENP) has released positive results from a 12-week follow-up on Cohort 1 of the Phase 2 trial of TRP-8803 IV-infused…...
Hengrui Pharmaceuticals' Lung Cancer Drug Included in China's Breakthrough Therapy Designation List
14+ hour, 5+ min ago (69+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. Jiangsu Hengrui Pharmaceuticals Co.,Ltd Hengrui Pharmaceuticals' Lung Cancer…...
Aptar Pharma Expands Preservative Free Technology Production in Latin America
10+ hour, 37+ min ago (318+ words) BioSpace Aptar Pharma Expands Preservative Free Technology Production in Latin America Transfer of Aptar Pharma’s Advanced Preservative Free pump technology to Berazategui, Argentina, strengthens local manufacturing capabilities and supports the company’s local-for-local approach in the region. Located south of Buenos…...